 | 3 Groundbreaking Genomics Stocks to Buy Now (NVTA) marketbeat.com - January 8 at 6:58 PM |
 | Invitae (NYSE:NVTA) Stock Rating Lowered by BidaskClub marketbeat.com - December 16 at 7:33 AM |
 | Invitae (NYSE:NVTA) Rating Increased to Hold at Zacks Investment Research marketbeat.com - November 18 at 5:20 AM |
 | Zacks Investment Research Downgrades InVitae (NYSE:NVTA) to Hold marketbeat.com - October 16 at 5:26 AM |
 | InVitae (NYSE:NVTA) Coverage Initiated at Morgan Stanley marketbeat.com - September 9 at 7:11 AM |
 | InVitae (NYSE:NVTA) Price Target Raised to $37.25 marketbeat.com - August 5 at 8:37 AM |
 | Invitae teams up with healthcare giants to develop MRD detection panel - Seeking Alpha seekingalpha.com - January 14 at 8:55 PM |
 | Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) - PRNewswire prnewswire.com - January 14 at 8:55 PM |
 | Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) finance.yahoo.com - January 14 at 8:55 PM |
 | Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform - GlobeNewswire globenewswire.com - January 13 at 10:31 PM |
|
 | Invitae (NYSE:NVTA) Stock Price Up 7.9% americanbankingnews.com - January 13 at 9:41 PM |
 | Why Invitae Stock Flew Higher Today - Motley Fool fool.com - January 13 at 5:31 PM |
 | Why Is It Moving? Looking At Invitae's Price Action Today - Benzinga benzinga.com - January 13 at 12:30 PM |
 | Concert Genetics Launches Preferred Laboratory Network - PRNewswire prnewswire.com - January 13 at 7:29 AM |
 | News Flash: 8 Analysts Think Invitae Corporation (NYSE:NVTA) Earnings Are Under Threat - Yahoo Finance finance.yahoo.com - January 13 at 7:29 AM |
 | News Flash: 8 Analysts Think Invitae Corporation (NYSE:NVTA) Earnings Are Under Threat finance.yahoo.com - January 13 at 7:29 AM |
 | These 3 Big 2020 Stock Market Winners Took Big Hits Monday - Motley Fool fool.com - January 12 at 8:32 AM |
 | Notable Monday Option Activity: NVTA, ATSG, KTB nasdaq.com - January 12 at 3:31 AM |
 | Invitae (NYSE:NVTA) Stock Price Down 10.2% americanbankingnews.com - January 11 at 9:16 PM |
 | Looking Into Invitae's Return On Capital Employed - Yahoo Finance finance.yahoo.com - January 11 at 5:20 PM |
 | Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume - Yahoo Finance finance.yahoo.com - January 11 at 5:20 PM |
 | Looking Into Invitae's Return On Capital Employed benzinga.com - January 11 at 12:18 PM |
 | A new JPM: Biotech's big meeting week goes virtual with swag and questions - San Francisco Business Times bizjournals.com - January 8 at 3:05 PM |
 | NVTA Crosses Above Average Analyst Target - Nasdaq nasdaq.com - January 8 at 3:05 PM |
 | Invitae (NYSE:NVTA) Trading 5.9% Higher americanbankingnews.com - January 5 at 9:18 PM |
 | We Found a Bubble—but It May Not Be What You Think It Is finance.yahoo.com - January 1 at 1:14 PM |
 | We Found a Bubble–but It May Not Be What You Think It Is finance.yahoo.com - December 31 at 7:21 PM |
 | Invitae (NYSE:NVTA) Trading Down 5.4% americanbankingnews.com - December 31 at 7:14 PM |
 | Colorado biotech firms raised a combined $2.6 billion in 2020 - Denver Business Journal bizjournals.com - December 31 at 12:01 AM |
 | Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference - Yahoo Finance finance.yahoo.com - December 29 at 7:58 AM |
|
 | Jason W. Myers Sells 48,971 Shares of Invitae Co. (NYSE:NVTA) Stock americanbankingnews.com - December 29 at 5:44 AM |
 | Are Genomic Stocks Are The Next FANG Stocks? - Yahoo Finance finance.yahoo.com - December 24 at 1:48 PM |
 | Best Biotech Stocks to Buy for 2021 - TheStreet thestreet.com - December 24 at 1:48 PM |
 | Are Genomic Stocks Are The Next FANG Stocks? - Benzinga benzinga.com - December 24 at 8:48 AM |
 | The Top Five Hypergrowth Industries I'm Targeting In 2021 - Forbes forbes.com - December 23 at 12:12 PM |
 | Global Prenatal Testing and Newborn Screening Market Report 2020-2030: COVID-19 Growth and Change - Market to Recover in 2023 to Reach $6.04 Bn after a -4.79% Decline in 2020 - Yahoo Finance finance.yahoo.com - December 22 at 5:29 AM |
 | Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years - Business Insider businessinsider.com - December 21 at 5:41 PM |
 | Invitae: Network Strategy And Industry Tailwinds Should Offer Path To Profitability - Seeking Alpha seekingalpha.com - December 21 at 7:39 AM |
 | Is BJ Stock Buy Or Sell? - Yahoo Finance finance.yahoo.com - December 20 at 7:56 PM |
 | Invitae Corp (NVTA) COO Kenneth D. Knight Sold $680,901 of Shares - Yahoo Finance finance.yahoo.com - December 19 at 1:37 AM |
 | Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster - PRNewswire prnewswire.com - December 17 at 6:19 PM |
 | Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster - Yahoo Finance finance.yahoo.com - December 17 at 1:18 PM |
 | Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster finance.yahoo.com - December 17 at 8:17 AM |
 | Colorado's Life Sciences Ecosystem Raises $1.2 Billion in 2020 - Business Wire businesswire.com - December 15 at 2:07 PM |
 | Genomics testing provider ArcherDX officially withdraws $100 million IPO following acquisition by Invitae - Nasdaq nasdaq.com - December 14 at 11:04 PM |
 | Notable Friday Option Activity: VIAC, NVTA, NVAX nasdaq.com - December 12 at 10:24 AM |
 | Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Symposium - PRNewswire prnewswire.com - December 9 at 8:28 AM |
 | Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Symposium finance.yahoo.com - December 9 at 8:28 AM |
 | Stock Alert: Invitae Corporation Touches New High - Nasdaq nasdaq.com - December 7 at 5:03 PM |
 | New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients - PRNewswire prnewswire.com - November 19 at 6:05 PM |
 | New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients finance.yahoo.com - November 19 at 1:05 PM |
 | Imagine Holding Invitae (NYSE:NVTA) Shares While The Price Zoomed 557% Higher - Yahoo Finance finance.yahoo.com - November 11 at 12:40 AM |
 | Imagine Holding Invitae (NYSE:NVTA) Shares While The Price Zoomed 557% Higher finance.yahoo.com - November 10 at 12:38 PM |
 | Invitae: Growth With Massive Dilution seekingalpha.com - November 9 at 8:21 PM |
 | Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1 - GlobeNewswire globenewswire.com - November 9 at 10:20 AM |
 | Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020 - Yahoo Finance finance.yahoo.com - November 7 at 7:53 PM |